Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02944396
Title Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham - Main /ID# 155135 Birmingham Alabama 35233 United States Details
Icri /Id# 155593 Whittier California 90603 United States Details
Univ of Colorado Cancer Center /ID# 153820 Aurora Colorado 80045 United States Details
University of Chicago /ID# 153824 Chicago Illinois 60637-1443 United States Details
Goshen Center for Cancer Care /ID# 153822 Goshen Indiana 46526 United States Details
Duke University Medical Center /ID# 153821 Durham North Carolina 27710-3000 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field